News and Events

A major driver of AMR is the inappropriate use of antimicrobials. This is a common issue in many resource-limited countries with poor access to the correct medicines and treatment. To prevent antimicrobials from becoming ineffective against infections, antimicrobial use surveillance data is critical for guiding and monitoring antibiotic access and usage.

A new Regional Grant for phase 2 of the Fleming Fund, GEAR up (Gender and Equity within Antimicrobial Resistance) is led by the Liverpool School of Tropical Medicine (LSTM) in the UK.

The Burnet Institute, Fleming Fund Country Grant lead for Papua New Guinea, unveiled two national AMR laboratories, marking a significant milestone for PNG healthcare.

The fifth Fleming Fellows Symposium welcomed the new phase 2 fellows, Fleming alumni, and the Africa Leadership Antimicrobial Stewardship (ALF-A) fellows from the Commonwealth Pharmacy Association.

The GRAM project led by Institute for Health Metrics and Evaluation and the University of Oxford and funded by the UK Department of Health and Social Care’s Fleming Fund and Wellcome, released the latest GRAM paper, published in The Lancet.

SeqAfrica has launched the second phase of its work in Sub-Saharan Africa with a £3.6 million (DKK 31 million) Regional Grant from the UK government’s Fleming Fund.

On One Health Day, we introduce the AMROH-SEA project, which is a Fleming Fund Regional Grant led by the Asia-Pacific Centre for Animal Health, University of Melbourne. This is part of the new AMR One Health series of four grants initiated in phase 2 of the Fleming Fund to support the development of national surveillance systems across the regions it operates.

At the UN General Assembly High-Level Meeting (UNGA-HLM) on antimicrobial resistance (AMR) in New York, governments signed a Political Declaration setting the agenda for global action to tackle the growing threat and work towards healthcare equity.

The British Embassy Hanoi, in collaboration with FHI 360 launched the second phase of the UK’s Fleming Fund Country Grant (FFCG) – awarded £3.4M for Vietnam to continue their vital work on tackling antimicrobial resistance (AMR).

The UK aid Fleming Fund Country Grant to Indonesia (FFCGI) enters its second phase of support to Indonesia, providing technical assistance to the country’s government in addressing the threat of antimicrobial resistance (AMR) - with a new investment of GBP 5.8 million/IDR 120 billion from 2024-2026.